Unichem Laboratories Ltd. — Capital/Financing Update 2019

Jul 5, 2019

July 5, 2019

Department of Corporate Services

Bombay Stock Exchange, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001.

Mr. Hari K. Asst. Vice President - Operations National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051.

Ref: BSE Scrip Code-506690 : NSE Symbol- UNICHEMLAB

Dear Sir,

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

We wish to inform you that that a Wholly Owned Subsidiary (WOS) of the Company has been incorporated in China on June 27, 2019 under the name "Younikaimo Pharmaceutical (Shanghai) Pvt. Ltd." [Unichem ·(china) Pvt. Ltd]. The business license and various clarifications on the same were received by the Company on July 4, 2019 and accordingly the information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, is given as under:

Sr.	Particulars	Status/Remark
No.
1.	Name of the Target entity, details in brief such as size, turnover etc.	The Company on June 27, 2019 has set up a WOS in China called" "Younikaimo Pharmaceutical (Shanghai) Pvt. Ltd." [Unichem (China) Pvt. Ltd.] Size turnover etc. is not applicable since this pertains to the incorporation of a WOS
2.	Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arms length".	No, acquisition does not fall within related party transaction since it is formation of a WOS and the promoter/ promoter group do not have any interest in the WOS.
3.	Industry to which the entity being acquired belongs	to The newly incorporated WOS belongs Pharmaceutical industry and its main objects are mentioned in para 4.
4.	Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity);	Objects: Sale in China of Formulations and Active Pharmaceutical Ingredients manufactured by Unichem Laboratories Ltd, after obtaining necessary Chinese regulatory permissions
		Enable efficient sourcing and supply of materials from China.
		i

R~ ~istered Office: Unichem Bhavan, Prabhat Estate, Off S. V. Road, Jogeshwari (West), Mumbai - 400 102, Maharashtra, India. T~ +91 (22) 66888333 • Fax.: +91 (22) 26784391 • Website: www.unichemlabs.com • CIN: L99999MH1962PLC012451

Sr.	Particulars	Status/Remark
No.
5.	Brief details of any governmental or	Not Applicable, since the Target Company is
	regulatory approvals required for the	incorporated as a WOS.
	acquisition;
6.	Indicative time period for completion of	Not Applicable, since from inception the Target
7.	the acquisition Nature of consideration - whether cash	Company is formed as a WOS. Not Applicable, since the Target Company is
	consideration or share swap and details	incorporated as a WOS.
	of the same
		The authorized capital of the said WOS is USO 2.5
		million and the Company will initially subscribe to
		shares to the tune of USO 0.2 Million.
		The process of subscription to the share capital of the said WOS is under process.
8.	Cost of acquisition or the price at which	Not applicable since the Target Company is
	the shares are acquired	incorporated as a WOS.
9.	Percentage of shareholding/ control	The Company will hold 100% share capital of the
	acquired and/ or number of shares	said WOS.
	acquired;
		The authorized capital of the said WOS is USO 2.5
		million and the Company will initially subscribe to
		USO 0.2 Million of the share capital of the said wos.
		The process of subscription to the share
		capital of the said WOS is under process.
10.	Brief background about the entity	The said WOS is set up to carry Pharmaceutical
	acquired in terms of products/line of	and allied activities. The main objects of the WOS
	business acquired, date of incorporation,	is given under point no. 4 above.
	history of last 3 years turnover, country
	in which the acquired entity has presence and any other significant	History of last 3 years is not applicable for the said
	information (in brief);	WOS is incorporated on June 27, 2019.

Please take this on record.

For UNICHEM ·LA. BORATORIE:>IMITED

GA, <-V. c~~~cf\x

NEEMA THAKORE Head- Legal & Company Secretary